Table 2.
Primary and secondary outcomes at days 7 and 14
| Outcome/time | Treatment (n = 36) | Control (n = 36) | Absolute difference (95% CI) | Effect estimate (95% CI) | ||
|---|---|---|---|---|---|---|
| Abnormal chest X-ray, No. (%) | ||||||
| Day 1 | 11 (31%) | 9 (25%) | 0.06 | (−0.15 to 0.26)a | 1.22 | (0.58 to 2.59)c |
| Day 14 | 12 (33%) | 11 (31%) | 0.03 | (−0.19 to 0.24)a | 1.09 | (0.56 to 2.14)c |
| Positive PCR CT ratio, No. (%) | ||||||
| Day 1 | 36 (100%) | 36 (100%) | 0.00 | (0.00 to 0.00)a | 1.00 | (1.00 to 1.00)c |
| Day 7 | 29 (81%) | 30 (83%) | −0.03 | (−0.21 to 0.15)a | 0.97 | (0.78 to 1.20)c |
| Day 14 | 19 (53%) | 20 (56%) | −0.03 | (−0.26 to 0.20)a | 0.95 | (0.62 to 1.45)c |
| PCR CT ratio, Mean ± SD | ||||||
| Day 1 | 23.65 ± 7.12 | 22.05 ± 5.10 | 1.60 | (−1.31 to 4.51)b | ||
| Day 7 | 25.99 ± 12.90 | 24.72 ± 11.17 | 1.27 | (−4.48 to 7.03)b | ||
| Day 14 | 17.43 ± 16.82 | 18.51 ± 17.34 | −1.09 | (−9.12 to 6.95)b | ||
| N gene, Mean ± SD | ||||||
| Day 1 | 23.36 ± 6.20 | 22.42 ± 5.46 | 0.93 | (−1.81 to 3.68)b | ||
| Day 7 | 28.62 ± 11.10 | 26.22 ± 10.60 | 2.21 | (−3.04 to 7.45)b | ||
| Day 14 | 20.02 ± 17.29 | 19.17 ± 17.09 | 0.85 | (−7.23 to 0.93)b | ||
aAbsolute difference is the difference in proportions
bAbsolute difference is the mean difference
cEffect estimate is the risk ratios (RR)